UnitedHealth Group Outperforms Market with Strong Earnings Growth

UnitedHealth Group (UNH) has been outperforming the market over the past 15 years, producing an average annual return of 15.19%. According to a recent analysis by Zacks, UNH's stronger six-month return and improving UnitedHealthcare and Optum results make it the better buy compared to CVS. The report highlights that UNH has attractive valuation and is poised for growth.

Another study by Zacks shows that CI's Smart Coverage can help close health-cost gaps by linking medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events. However, billionaire David Tepper recently sold every single share of UnitedHealth in Q2, sparking questions about his investment strategy.

Analysts argue that while UnitedHealth's cost pressures are real, margins and earnings growth show signs of improvement. The company is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing, and cost controls to boost margins. This shift is expected to drive performance in the Zacks Medical-HMO industry.

With an aging U.S. population, digital transformation, a diversified membership mix, and strategic M&A driving the industry's prospects, UNH, CI, HUM, CNC, and MOH are poised to benefit from favorable market conditions.